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IMPORTANCE—Microglia, the resident immune cells of the central nervous system, play an
important role in the brain’s response to injury and neurodegenerative processes. It has been
proposed that prolonged microglial activation occurs after single and repeated traumatic brain
injury, possibly through sports-related concussive and subconcussive injuries. Limited in vivo
brain imaging studies months to years after individuals experience a single moderate to severe
traumatic brain injury suggest widespread persistent microglial activation, but there has been little
study of persistent glial cell activity in brains of athletes with sports-related traumatic brain injury.
OBJECTIVE—To measure translocator protein 18 kDa (TSPO), a marker of activated glial cell
response, in a cohort of National Football League (NFL) players and control participants, and to
report measures of white matter integrity.

Author Manuscript

DESIGN, SETTING, AND PARTICIPANTS—This cross-sectional, case-control study included
young active (n = 4) or former (n = 10) NFL players recruited from across the United States, and
16 age-, sex-, highest educational level-, and body mass index-matched control participants. This
study was conducted at an academic research institution in Baltimore, Maryland, from January 29,
2015, to February 18, 2016.
MAIN OUTCOMES AND MEASURES—Positron emission tomography-based regional
measures of TSPO using [11C]DPA-713, diffusion tensor imaging measures of regional white
matter integrity, regional volumes on structural magnetic resonance imaging, and
neuropsychological performance.

Author Manuscript

RESULTS—The mean (SD) ages of the 14 NFL participants and 16 control participants were
31.3 (6.1) years and 27.6 (4.9) years, respectively. Players reported a mean (SD) of 7.0 (6.4) years
(range, 1–21 years) since the last self-reported concussion. Using [11C]DPA-713 positron emission
tomographic data from 12 active or former NFL players and 11 matched control participants, the
NFL players showed higher total distribution volume in 8 of the 12 brain regions examined (P < .
004). We also observed limited change in white matter fractional anisotropy and mean diffusivity
in 13 players compared with 15 control participants. In contrast, these young players did not differ
from control participants in regional brain volumes or in neuropsychological performance.
CONCLUSIONS AND RELEVANCE—The results suggest that localized brain injury and
repair, indicated by higher TSPO signal and white matter changes, may be associated with NFL
play. Further study is needed to confirm these findings and to determine whether TSPO signal and
white matter changes in young NFL athletes are related to later onset of neuropsychiatric
symptoms.
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Increasing evidence supports the complex role of microglia, the resident immune cells of the
central nervous system, in response to brain injury and neurodegenerative processes.1
Widespread persistent microglial activation has been detected in a limited number of small
in vivo brain imaging studies of individuals months to years after a single traumatic brain
injury (TBI).2,3 Nevertheless it is unclear whether prolonged microglial activation occurs
after TBI or repeated TBI incurred through sports-related concussive and subconcussive
injuries. New techniques designed to image markers of glial cell activation in vivo promise
to help uncover whether sports-related TBI elicits acute and prolonged glial response.
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The translocator protein 18 kDa (TSPO) is normally expressed at low levels in brain tissue
but is increased in expression by activated microglia, as well as reactive astrocytes.4
Therefore, TSPO is a proposed biomarker for brain injury and repair that can now be
measured in living patients using radiotracers and positron emission tomographic (PET)
imaging.5,6 Recently, we characterized the use of [11C]DPA-713 with PET to image the
distribution of TSPO in health and disease,7 including correction for the effect of a common,
genetic polymorphism on [11C]DPA-713 binding to TSPO.8 In a cross-sectional pilot study
of older former National Football League (NFL) players and control participants, TSPO PET
signal was significantly higher in the right amygdala and bilateral supramarginal gyri of the
players compared with control participants.9

Author Manuscript

In vivo study of brain tissue changes in athletes playing collision sports has largely focused
on detection of white matter tract changes using diffusion tensor imaging (DTI), which is
based on the estimates of water movement in brain tissue.10 Previous studies suggest
widespread changes in white matter diffusion indices over one season of high school
participation in a collision sport.11–13 White matter diffusion indices have also been reported
in collegiate football players studied 6 months after concussion,14 although changed white
matter integrity may be clinically silent in high school and collegiate athletes with TBI.11,13

Author Manuscript

Here we combined high-resolution brain [11C]DPA-713 PET with assessment of white
matter integrity, regional volumes, and neuropsychological performance in a new population
of young active and former NFL players. Data from players were compared with data from
control participants who were matched to players in age, sex, highest educational level, and
body mass index (calculated as weight in kilograms divided by height in meters squared).
We tested the hypothesis that players have higher [11C]DPA-713 PET signal and altered
white matter integrity compared with control participants. Rather than focusing on older
former NFL players,9 we focused on young players because they are temporally closer to
NFL play and at less risk for cerebrovascular disease, which may also generate positive
signal on TSPO PET.15

Methods
Human Participants

Author Manuscript

A Johns Hopkins institutional review board approved this study, which was conducted from
January 29, 2015, to February 18, 2016. All participants provided written informed consent.
National Football League players engaged in active play and those who were recently retired
(defined as within 12 years of stopping play) were recruited through personal referrals by
one of the authors (C.J.N.) and word of mouth. Male control participants were recruited
through local advertising and completed a careful clinical interview to ensure stable health.
Clinical Assessment and Neuropsychological Testing
Participants underwent a standardized examination by a board-certified psychiatrist that
included questions about past and current athletic pursuits (including participation in
football and TBI for the NFL players) and medical and psychiatric history, as well as family
history of neuropsychiatric illness (including dementia and affective illness). Details about
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NFL play and past concussion, as defined by the Quality Standards Subcommittee of the
American Academy of Neurology,16 were obtained from the NFL players by self-report.
Participants completed the 17-item Hamilton Depression Scale (HAM-D).17 Control
participants denied history of substance dependence, neurological disorder, subjective
cognitive symptoms, participation in collegiate or professional collision sports, and TBI.
Participants denied current use of anti-inflammatory treatment, including over-the-counter
medications, and all were assessed for TSPO (rs6971) genotype as previously described.7
Participants completed a battery of neuropsychological tests (eTable 1 in the Supplement),
from which we chose representative tests for this study (eAppendix 1 in the Supplement).
In Vivo Brain Imaging

Author Manuscript

Radiotracer Synthesis and PET Acquisition—[11C]DPA-713 was synthesized as
previously described18 and met all US Pharmacopeia Chapter 823 acceptance testing
criteria. Radiochemical purity at end of synthesis was greater than 99%, with mean (SD)
specific activity of 342 (83) GBq per micromole (9245 [2255] mCi/μmol) at time of
injection. The mean (SD) injected dose was 684.0 (53.1) MBq. Key details about the
dynamic PET acquisition are included in eAppendix 2 in the Supplement and are identical to
those previously described.9

Author Manuscript

Magnetic Resonance Imaging Acquisition—Participants underwent brain magnetic
resonance imaging (MRI) on a Phillips Achieva 3-T scanner for structural T1-weighted
imaging (3-dimensional MPRAGE) with 1 × 1 × 1-mm resolution and DTI. Diffusion tensor
imaging parameters included single-shot echoplanar imaging; b-value of 700 seconds/mm2;
32 diffusion-weighting orientations with 5 b0 images; 70 gapless whole-brain axial sections
of 2.2-mm thickness; matrix of 96 × 96, field of view of 212 × 212 mm, and zero-filled to
256 × 256 mm. DtiStudio was used for data processing.19 Motion and eddy current were
monitored and corrected with an in-house affine transformation with a cost function based
on tensor fitting.20 Gradient tables were compensated for rotational motion. Tensor fitting
was performed by a RESTORE-type in-house outlier rejection method.21
Data Analysis and Statistics

Author Manuscript

PET Data Analysis—The software package PMOD (version 3.3; PMOD Technologies
Ltd) was used in the initial PET image processing and kinetic analysis. Interframe motion
correction and PET-MRI coregistration were completed as previously described.9 Cortical
reconstruction and volumetric segmentation of T1-weighted MRIs were performed with the
FreeSurfer image analysis suite (http://surfer.nmr.mgh.harvard.edu/). Twelve regions of
interest (ROIs), identical to those used previously,9 were selected for this study: right and
left side hippocampus, parahippocampus, entorhinal cortex, amygdala, temporal pole, and
supramarginal gyrus (eFigure 1 in the Supplement). Total cortical gray matter (GM) and
total intracranial volume (ICV) were also defined using FreeSurfer for use in secondary
analyses exploring the effect of (1) clinical characteristics on [11C]DPA-713 binding in GM
and (2) ROI volume normalized to ICV on regional binding.18 The primary PET-based
regional binding outcome was total distribution volume (VT).22
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Positron emission tomographic time-activity curves were generated for all participants using
the ROI definitions. Based on the time-activity curves obtained, VT within each ROI was
estimated using Logan graphical analysis23 (t* = 30 minutes) with the metabolite-corrected
arterial plasma input function. Plasma free fraction (fP) was measured using rapid
equilibrium dialysis as previously described18 and VT corrected for fP (VT/fP) was
calculated.

Author Manuscript

DTI Data Analyses—Diffusion tensor imaging data were analyzed by automated white
matter segmentation using MriStudio software.24,25 Briefly, an atlas with defined white
matter regions (JHU “Eve” Atlas) was warped to each patient image using large deformation
diffeomorphic metric mapping implemented in Diffeo-Map software. Fractional anisotropy
(FA) and mean diffusivity (MD) values of the 8 predefined white matter structures (eFigure
2 in the Supplement) were then measured using RoiEditor. These white matter regions were
selected because they contain long fibers that collectively project from subcortical structures
to widespread cortical tissue. Long axonal projections are potentially more vulnerable to
axonal injury from rapid biomechanical forces induced by hits to the head.26 While studies
implicate varied sites of white matter change after sports-related concussion,27 we focused
on right and left side anterior, superior, and posterior corona radiata, as well as posterior
thalamic radiation (PTR), because postseason changes in corona radiata and PTR have been
observed in young athletes playing collision sports.11,12,28 Using a 3-dimensional atlasbased approach, we overcame the limitation of tract-based methods in defining thalamic
radiations, which are difficult to define using a 2-dimensional plane.29
Statistical Analysis
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Statistical analyses of the primary PET outcome measure, regional VT, were performed with
multivariate general linear modeling using SPSS Statistics (version 22.0; IBM Corp). We
modeled the VT values obtained from the 12 selected ROIs based on their relationship to
between-participant factors, including cohort (NFL player or control) and TSPO genotype
(C/C: high affinity binder and C/T: mixed affinity binder) as independent fixed factors.
Participants with genotype T/T were excluded from this analysis of PET data owing to the
low affinity of [11C]DPA-713 for TSPO in individuals with T/T genotype. Similar analyses
were repeated for regional values, VT/fP.
All other statistical analyses were performed using R (R Foundation for Statistical
Computing).30 Demographic and clinical characteristics of NFL players vs control
participants were compared using 2-sample t tests for continuous variables and Fisher exact
test for categorical variables. Data were expressed as mean (SD) unless otherwise noted.
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The threshold for significance in all statistical tests involving regional VT and regional
volume measures was set as P < .004, taking into account the 12 ROIs using Bonferroni
correction (0.05/12 ≈ 0.0042). The threshold for significance in all statistical tests involving
the 8 white matter regions tested was set as P < .006 (approximately 0.05/8). Statistical
significance was otherwise defined as P < .05, except where otherwise noted.

JAMA Neurol. Author manuscript; available in PMC 2017 July 11.
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Results
Study Population
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Demographic characteristics and clinical characteristics of the NFL players and control
participants are in Table 1. A total of 14 NFL players (4 active and 10 recently retired; ages
24–39 years) and 16 control individuals (ages 21–37 years) participated. The 10 former NFL
players ended NFL play in a period that spanned a range of 1 to 144 months prior to
participation. Players reported a mean (SD) of 7.0 (6.4) years (range, 1–21 years) since the
last self-reported concussion. Other self-reported details about NFL play are listed in eTable
2 in the Supplement. On the HAM-D, 1 of the 14 players scored a 14, consistent with
moderate depressive symptoms, and 1 player scored an 11, indicating mild depressive
symptoms. All other participants were without depressive symptoms (HAM-D < 8). A
summary of the number of participants in each cohort with data from [11C]DPA-713 PET
imaging, structural MRI, DTI, and neuropsychological testing is in eTable 3 in the
Supplement.
Neuropsychological Assessment of Former NFL Players and Control Participants
Three control participants did not undergo neuropsychological assessment.
Neuropsychological test results from the 1 player with a HAM-D score of 14 were excluded
owing to his scores on a performance validity measure (Word Memory Test).31 There were
no differences in neuropsychological test scores between the remaining 13 players and 13
control participants after correction for multiple comparisons (Table 2).
Structural MRI and Volumetric Analyses
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No evidence of structural abnormality was present on T1-weighted MRI. Quantitative
analysis of the MRI-based segmentation results for the 12 ROIs showed no significant
difference between young NFL players and control participants in regional volume
normalized to ICV (eTable 4 in the Supplement).
[11C]DPA-713 PET Imaging
Three control participants lacked arterial input function measurement, 1 control participant
was excluded for T/T TSPO genotype, and 2 individuals (1 control and 1 player) had
insufficient PET imaging due to scanner malfunction. One player (with C/C genotype)
reported taking a creatine supplement and had unusually low binding across all brain regions
(eTable 5 in the Supplement). Positron emission tomographic data from this outlier were
removed from primary analyses because of previously published evidence that creatine use
may lower TSPO PET signal.32 No other participants reported use of creatine supplements.

Author Manuscript

In 2-way analysis of variance, with genetic group (C/C vs C/T) and cohort (players vs
control participants) as independent fixed factors, VT values between 12 NFL players and 11
control participants differed significantly in the left and right hippocampus, left entorhinal
cortex, left and right parahippocampal cortex, left and right supramarginal gyrus, and left
temporal pole (Figure 1; eTable 5 in the Supplement). Correction of VT for plasma free
fraction (VT/fP) did not change the results. Data from the 9 former players alone compared
with control participants also revealed higher VT values in players in these regions (eTable 6
JAMA Neurol. Author manuscript; available in PMC 2017 July 11.
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in the Supplement). Multivariate regressions using data from participants, controlling for
genotype, showed no significant effect of ROI volume normalized to total ICV on VT in
each of the 12 ROIs. Exploratory analyses of the effects of demographic and NFL playrelated characteristics on [11C]DPA-713 VT in GM showed NFL players had higher VT in
GM compared with control participants, but there was no significant effect of age, race/
ethnicity, body mass index, or years of education on VT in GM (eTable 7 in the
Supplement). Among the NFL cohort, there was also no observed effect of actively playing
(vs being a former player), duration of retirement, years of play in the NFL, number of NFL
games played, number of self-reported concussions, age at first self-reported concussion, or
years since last self-reported concussion on VT in GM.
Diffusion Tensor Imaging

Author Manuscript

Diffusion tensor imaging data from 1 player and 1 control participant were excluded owing
to severe motion artifact and claustrophobia limiting scan time, respectively. Of the 13 NFL
players and 15 control participants with DTI data, FA values were significantly lower in the
right posterior thalamic radiation of NFL players compared with control participants (Table
3). Mean diffusivity values in the left anterior corona radiata were significantly higher in
NFL players compared with control participants. Fractional anisotropy and MD values in the
other white matter ROIs did not differ from those of control participants.

Discussion

Author Manuscript

Recent research supports an expanded role for microglia, the resident immune cells of the
central nervous system, across the human lifespan and in disease.33–35 Because activated
microglia can influence synaptic remodeling and white matter recovery after TBI,36·37
characterization of glial activation close to the time of NFL play may elucidate the
relationship between microglial response, tissue micro-structural organization, and
symptoms. The increased expression of TSPO by activated glia (microglia and reactive
astrocytes) is the basis of several promising PET-based imaging methods to measure brain
injury and repair in vivo.6,38–42

Author Manuscript

The current study extends our earlier findings of higher regional [11C]DPA-713 VT values in
older former NFL players compared with control participants9 to a new cohort of younger
NFL players compared with matched control participants (Figure 1). We measured TSPO
binding in the same temporal and parietal cortical regions as well as the mesial temporal
lobe structures as in our previous study. Visual inspection of [11C]DPA-713 parametric PET
images implicates high binding in the thalamus and midbrain regions in young NFL players
as well (Figure 2). The collective results from this and our previous study suggest potential
vulnerability of the supramarginal gyrus to injury from TBI in football that warrants further
investigation. Furthermore, higher TSPO signal in the left temporal pole and mesial
temporal lobe structures of young NFL players compared with control participants provides
in vivo evidence of hypothesized vulnerability of these regions to biomechanical forces
incurred through sports-related TBI.26
We aimed to assess TSPO signal in parallel with white matter organization, regional volume,
and neuropsychological performance. Looking across the widespread white matter area

JAMA Neurol. Author manuscript; available in PMC 2017 July 11.
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covered by bilateral subsections of the coronal radiata and bilateral PTR, we observed lower
FA, a nonspecific but potential indicator of lower white matter integrity, in the right PTR of
the NFL players compared with control participants. Mean diffusivity, often observed as
inverse of FA and reflecting the magnitude of white matter change,10 was higher in NFL
players compared with control participants in the left anterior corona radiata. Irrespective of
these white matter diffusion findings, we did not see a difference in regional volumes
normalized to ICV, nor difference in performance on selected neuropsychological tests
between these cohorts of young individuals. Marked pathological changes to susceptible
brain regions and associated cognitive, affective, and behavioral symptoms may take
decades to emerge after participation in collision sport.26,43 Together our results support
emerging evidence from mouse studies of persistent microglial activation after head trauma
that may increase susceptibility to later cognitive deficits.44,45 Therefore, therapeutic and
preventive interventions before onset of clinical decline may be possible.
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Strengths and Limitations
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A strength of this study is the focus on relatively young NFL players who are closer to the
time of play and are less likely to have cerebrovascular disease, which is independently
associated with inflammation and white matter changes. Still, the players in this study
reported a mean (SD) of 7.0 (6.4) years since last concussion. The temporal relationship
between increased TSPO expression and sports-related TBI may be best elucidated using a
longitudinal design with [11C]DPA-713 PET imaging from the time of measured head
impact. It is also important to note that [11C]DPA-713 PET signal is only an indirect
measure of microglial activation in the living brain, and DTI outcome measures, such as FA
and MD, are only indirectly representative of underlying white matter structure. Our results
support further in vitro experiments of activated microglia and white matter tract anatomy
directly in carefully selected postmortem tissue from players of all ages.46

Conclusions
By demonstrating higher TSPO PET signal and altered DTI indices in several brain regions
of young NFL players, we support future use of [11C]DPA-713 PET and DTI to examine
these markers associated with brain injury and repair in athletes playing collision sports.
Because there is interest in targeting microglial pathways and immune modulation to prevent
neurodegeneration,37,47,48 further human studies using [11C]DPA-713 PET and DTI in
individuals with history of sports-related TBI may inform strategies for future translational
research and immune-based interventions.
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Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Key Points
Question
Is localized brain injury, indicated by higher translocator protein signal and white matter
changes, linked to National Football League (NFL) play?
Findings
In this cross-sectional, case-control study of young NFL players compared with control
participants, players showed higher translocator protein positron emission tomographic
signal in 8 of 12 regions examined. Limited significant white matter changes were also
observed in NFL players compared with control participants, although players and
control participants did not differ in regional brain volumes or neuropsychological
performance.
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Meaning
These results suggest that localized brain injury may be associated with NFL play,
although further study is needed to test links to onset of neuropsychiatric symptoms.
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Figure 1. Scatter Plots of Regional Total Distribution Volume Values in Active and Recently
Retired National Football League (NFL) Players and Control Individuals Injected With
[11C]DPA-713
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Individual total distribution volume data from NFL and control cohorts are shown along
with mean (SD) values. Using 2-way analysis of variance with genetic group (C/C vs C/T)
and cohort (NFL vs control) as independent fixed factors, regional total distribution volume
values in 8 of the 6 right and left side regions (12 total regions) were significantly higher
than those of control participants. The threshold for significance after accounting for
multiple comparisons was P < .06/12 = .004.
aP < .004.
bP < .001.
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Figure 2. Former National Football League (NFL) Players Demonstrate Higher Binding of
[11C]DPA-713 Across Many Brain Regions Compared With the Brains of Age-, Sex-, Education-,
and Body Mass Index-Matched Control Individuals

A, Mean parametric [11C]DPA-713 total distribution volume (VT) images displayed in
groups of 3 views (left to right: axial, sagittal, and coronal) from 6 controls (left 3 views)
and 5 NFL players (right 3 views) with C/T rs6971 genotype are presented. B, Mean
parametric [11C]DPA-713 VT images from 5 controls (left 3 views) and 7 NFL players (right
3 views) with C/C rs6971 genotype are presented.
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Clinical and Demographic Characteristics
Characteristic

NFL
(n = 14)

Control
(n = 16)

Age, mean (SD), y

31.3 (6.1)

27.6 (4.9)

3 (21)

3 (19)

11 (79)

13 (81)

BMI, mean (SD)

30.8 (3.3)

28.5 (5.3)

.17

Duration of education, mean (SD), y

16.8 (1.0)

16.9 (2.1)

.80

C/C

7 (58)

5 (45)

C/T

5 (42)

6 (55)

P Valuea
.08

Race, No. (%)
African American

>.99
White

rs6971 TSPO genotype, No. (%)
.68

Author Manuscript

Players, No. (%)
Active

4 (29)

NA

NA

Retired

10 (71)

NA

NA

Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); C/C, high affinity binder; C/T,
mixed affinity binder; NA, not applicable; NFL, National Football League.

a

P values for t test or Fisher exact test as appropriate. Threshold for significance, P < .05.
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Neuropsychological Performance in NFL Players and Control Participants
Mean (SD) [Range]
NFL Players
(n = 13)a

Controls
(n = 13)a

Wechsler Test of Adult Reading

110.4 (14.4)
[75–128]

117.3 (5.2)
[105–122]

.12

Mini-Mental State Examination

27.2 (1.7)
[24–29]

28.7 (1.3)
[26–30]

.02

Part A

19.3 (4.2)
[13–25]

21.9 (6.9)
[15–38]

.25

Part B

49.0 (19.4)
[26–93]

41.2 (9.8)
[24–56]

.21

Wechsler Adult Intelligence Scale-IV Coding, raw score

69.2 (14.3)
[45–97]

82.6 (13.9)
[62–104]

.03

Phonemic fluency, No. of words in 2 min

33.8 (11.3)
[22–58]

36.9 (8.4)
[27–54]

.43

Trials 1–5, raw score (of 80 possible)

60.2 (9.7)
[46–76]

68.3 (7.9)
[48–78]

.03

Delayed free recall, raw score (of 16 possible)

14.2 (1.6)
[12–16]

15.0 (1.7)
[10–16]

.21

Test

P Valueb

Trail Making Test, s

Author Manuscript

CVLT-2

Abbreviations: CVLT, California Verbal Learning Test-2; NFL, National Football League.

a

Data from 1 NFL player with moderate depressive symptoms (Hamilton Depression Scale score = 14) was not included in this comparison of
neuropsychological performance between cohorts because of a low score on the initial test of effort (Word Memory Test). Three of the 16 control
participants in the study did not complete the neuropsychological assessment.

b
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P values from t tests, with threshold for significance defined as P < .05/8 = .006 accounting for multiple tests.

Author Manuscript
JAMA Neurol. Author manuscript; available in PMC 2017 July 11.

Author Manuscript

Author Manuscript

Author Manuscript

0.513 (0.017)

0.503 (0.017)

Right

0.411 (0.020)

Right

0.440 (0.018)

Right

0.434 (0.030)

Right

0.415 (0.028)

0.410 (0.022)

0.419 (0.021)

0.419 (0.019)

0.404 (0.022)

0.390 (0.017)

0.482 (0.018)

0.493 (0.020)

.10

.01

.03

.01

.40

0.0024 (0.0002)

0.0023 (0.0002)

0.0022 (0.0001)

0.0022 (0.0001)

0.0025 (0.0001)

0.0024 (0.0000)

0.0026 (0.0001)

.005c

.052

0.0025 (0.0002)

.01

0.0025 (0.0001)

0.0023 (0.0002)

0.0023 (0.0001)

0.0022 (0.0001)

0.0026 (0.0000)

0.0025 (0.0000)

0.0026 (0.0001)

0.0025 (0.0001)

NFL Players
(n = 13)a

.19

.90

.049

.31

.02

.003c

.26

.24

P Valueb

JAMA Neurol. Author manuscript; available in PMC 2017 July 11.

Accounting for the 8 selected ROIs, the threshold for significance was P < .05/8 = .006.

c

P values for t tests across the 8 selected ROIs.

b

claustrophobia limiting scan time. Most of these participants also have [11C]DPA-713 positron emission tomographic data.

FA and MD values reported for the NFL players and control participants for whom there are diffusion tensor imaging data after excluding data from 1 player and 1 control participant owing to severe
motion artifacts and

a

Abbreviations: ACR, anterior corona radiata; FA, fractional anisotrophy; MD, mean diffusivity; NFL, National Football League; PCR, posterior corona radiata; PTR, posterior thalamic radiation; ROI,
region of interest; SCR, superior corona radiata.

0.433 (0.026)

Left

PCR

0.440 (0.020)

Left

SCR

0.404 (0.018)

Left

ACR

P Valueb

Controls
(n = 15)a

NFL Players
(n = 13)a

Controls
(n = 15)a

Left

PTR

ROI

MD

FA

Mean (SD)

Comparison of FA and MD Values From Diffusion Tensor Imaging of NFL Players and Control Participants
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